Anthony Noble

Dr Noble has worked across research, operational leadership, and strategic advisory roles in both listed and private companies. Anthony currently serves as Executive Director at Servatus Biopharmaceuticals and as a Non-Executive Director of The Calmer Co International, following four years as Managing Director and Chief Executive Officer. Prior to these roles, Anthony founded Australian Biotherapeutics and spent a decade with SFI Health, contributing across clinical research, product development, and business expansion initiatives. Anthony played a key role in driving growth through both organic strategies and multiple mergers and acquisitions across Europe, Australia, North America, and Asia. With experience in North Asian markets, Anthony has served as General Manager of both SFI-Shineway in China and SFI Korea. Anthony brings international expertise and understanding of business development.